User profiles for J. T. Giles

Jon T Giles

Columbia University
Verified email at columbia.edu
Cited by 9809

Aggregatibacter actinomycetemcomitans–induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis

…, A Rosen, PA Nigrovic, J Sokolove, JT Giles… - Science translational …, 2016 - science.org
A bacterial etiology of rheumatoid arthritis (RA) has been suspected since the beginnings of
modern germ theory. Recent studies implicate mucosal surfaces as sites of disease initiation…

Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions

P Raggi, J Genest, JT Giles, KJ Rayner, G Dwivedi… - Atherosclerosis, 2018 - Elsevier
JT Giles is supported by unrestricted research funding from Pfizer not associated with this
publication. G. Dwivedi is the Wesfarmers Chair in Cardiology at the Harry Perkins Institute of …

2017 American College of Rheumatology/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in …

…, M George, O Gewurz‐Singer, JT Giles… - Arthritis & …, 2017 - Wiley Online Library
Giles has received consulting fees from Genentech (less than $10,000). Dr. Johnson has …
Ginzler EM, Wallace DJ, Merrill JT, Furie RA, Stohl W, Chatham WW. Disease control and …

Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study

IB McInnes, L Thompson, JT Giles, JM Bathon… - Annals of the …, 2015 - ard.bmj.com
Objectives The interleukin-6 receptor (IL-6R) blocker tocilizumab (TCZ) reduces inflammatory
disease activity in rheumatoid arthritis (RA) but elevates lipid concentrations in some …

[PDF][PDF] Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis

JT Giles, SJ Bartlett, AC Gelber, S Nanda… - Arthritis Care & …, 2006 - academia.edu
Giles, MD, 5501 Hopkins Bayview Circle, Suite 1B.1, Baltimore, MD 21224. E-mail:
gilesjont@jhmi.… Giles JT, Bathon JM. Serious infections associated with anticytokine therapies in …

Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies

JT Giles, SM Ling, L Ferrucci, SJ Bartlett… - Arthritis Care & …, 2008 - Wiley Online Library
… and pharmacotherapies - Giles - 2008 - Arthritis Care & Research - Wiley Online Library
Giles had full access to all of the data in the study and takes responsibility for the integrity of …

Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors

NL Henry, JT Giles, D Ang, M Mohan… - Breast cancer research …, 2008 - Springer
Purpose Aromatase inhibitors (AIs) are increasingly used as adjuvant treatment of postmenopausal
women with hormone receptor-positive breast cancer. AIs are commonly associated …

Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of …

…, MH Buch, M Dougados, DL Bhatt, JT Giles… - Annals of the …, 2023 - ard.bmj.com
Objectives Evaluate risk of major adverse cardiovascular events (MACE) with tofacitinib
versus tumour necrosis factor inhibitors (TNFi) in patients with rheumatoid arthritis (RA) with or …

Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics

JT Giles, M Allison, RS Blumenthal, W Post… - Arthritis & …, 2010 - Wiley Online Library
… and disease characteristics - Giles - 2010 - Arthritis & Rheumatism - Wiley Online Library …
Giles had full access to all of the data in the study and takes responsibility for the integrity of …

[HTML][HTML] Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype

O FitzGerald, M Haroon, JT Giles… - Arthritis research & …, 2015 - Springer
This review focuses on the genetic features of psoriatic arthritis (PsA) and their relationship
to phenotypic heterogeneity in the disease, and addresses three questions: what do the …